Instituto Grifols S.A.
SpainAll drugs from this manufacturer
-
It is used to restore and maintain blood volume when a deficit has been demonstrated and the use of a colloid is considered appropriate.
Dosage form: solution for infusion
Active substance Dosage human albumin 0.200 g -
It is used to restore and maintain circulating blood volume when a volume deficit has been demonstrated and the use of a plasma substitute is considered appropriate.
Dosage form: solution for infusion
Active substance Dosage human albumin 200 mg -
It is used to restore and maintain circulating blood volume when a deficit has been demonstrated and the use of a plasma substitute is considered appropriate.
Dosage form: solution for infusion
Active substance Dosage human albumin 50 mg -
It is used for the treatment and prevention of bleeding in people with hemophilia B (congenital factor IX deficiency), helping to increase the amount of factor IX in the blood so that it can clot.
Dosage form: powder and solvent for solution for injection
Active substance Dosage factor ix 40 - 62,5 UI proteins 0,2 - 0,6 mg -
It is used for the treatment and prevention of bleeding in people with hemophilia A (factor VIII deficiency) and for the treatment of bleeding or surgical bleeding in patients with von Willebrand disease, especially when other treatments are not effective.
Dosage form: powder and solvent for solution for injection
Active substance Dosage factor viii 100 UI von willebrand factor 120 UI -
It is used for the treatment and prevention of bleeding in people with Hemophilia A. It is also used to treat bleeding and prevent bleeding during surgery in patients with von Willebrand disease, especially when other treatments are not effective.
Dosage form: powder and solvent for solution for injection
Active substance Dosage factor viii 250 UI von willebrand factor 300 UI -
It is used for the treatment and prevention of bleeding in people with hemophilia A (factor VIII deficiency) and for the treatment of bleeding and prevention of surgical bleeding in patients with von Willebrand disease, when other treatments are not effective or cannot be used.
Dosage form: powder and solvent for solution for injection
Active substance Dosage factor viii 500 UI von willebrand factor 600 UI -
It is used to treat adults, children, and adolescents with antibody deficiencies (such as in Primary or Secondary Immunodeficiency Syndrome) or to prevent measles in individuals who cannot be vaccinated. It is also used to treat certain autoimmune conditions such as primary immune thrombocytopenia, Guillain-Barré Syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat adults, children, and adolescents with antibody deficiencies (such as in Primary or Secondary Immunodeficiency Syndrome) and to prevent measles in individuals who cannot be vaccinated. It is also used to treat certain autoimmune conditions such as immune thrombocytopenia, Guillain-Barré Syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat adults, children, and adolescents who have a lack of antibodies (such as in Primary or Secondary Immunodeficiency Syndrome) or to prevent measles in people who cannot be vaccinated. It is also used to treat certain autoimmune diseases such as primary immune thrombocytopenia, Guillain-Barré Syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat adults, children, and adolescents who have insufficient levels of antibodies (such as in Primary or Secondary Immunodeficiency Syndrome) and to treat certain autoimmune conditions such as Immune Thrombocytopenia, Guillain-Barré Syndrome, Kawasaki Disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, and Multifocal Motor Neuropathy. It is also used to prevent measles in susceptible individuals.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 50 mg -
It is used to treat adults, children, and adolescents who do not have enough antibodies due to congenital or secondary deficiencies. It is also used to prevent measles in susceptible individuals and to treat certain autoimmune diseases such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 50 mg -
It is used to treat adults, children, and adolescents who have insufficient antibody levels (such as in Primary or Secondary Immunodeficiency Syndrome) or to prevent measles in people who cannot be vaccinated. It is also used to treat certain autoimmune conditions such as immune thrombocytopenia, Guillain-Barré Syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 50 mg -
It is used to treat adults, children, and adolescents who have insufficient levels of antibodies due to congenital or secondary deficiencies. It is also used to prevent measles in susceptible individuals and to treat certain autoimmune diseases such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 50 mg -
It is used to treat adults, children, and adolescents who do not have enough antibodies due to immunity deficiencies (primary or secondary). It is also used to prevent measles in susceptible individuals and to treat certain autoimmune diseases, such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 50 mg -
It is used for immediate prevention following wounds that may be contaminated with tetanus (if you have not been adequately vaccinated or if your immunization status is unknown) and for the treatment of tetanus that has already manifested.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage human tetanus immunoglobulin 250 UI -
It is used for immediate prevention following wounds that may be contaminated with tetanus (if adequate vaccination has not been received or if there is an antibody deficiency) and for the treatment of tetanus once clinical symptoms manifest.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage human tetanus immunoglobulin 500 UI -
It is used to protect against rabies after contact with an animal suspected of being infected, whether through a bite, scratch, or other wounds with saliva contact in the area.
Dosage form: solution for injection
Active substance Dosage human antirabies immunoglobulin 300 UI/ml -
It is used to prevent Rh(D) immunization in Rh(D) negative women, both during pregnancy (before or after complications) and after childbirth if the baby is Rh(D) positive. It is also used to treat Rh(D) negative individuals who have received an incompatible blood transfusion.
Dosage form: solution for injection
Active substance Dosage human anti-d immunoglobulin 750 UI/ml UI -
It is used for the prevention of hepatitis B in cases of accidental exposure in non-immunized individuals, in hemodialysis patients, in newborns of mothers who are carriers of the virus, and in people who did not respond to vaccination. It is also used to prevent reinfection in patients who have received a liver transplant due to failure caused by hepatitis B.
Dosage form: solution for injection
Active substance Dosage human antihepatitis b immunoglobulin 200 UI/ml UI -
It is used for the prevention of hepatitis B in cases of accidental exposure in non-immunized individuals, in hemodialysis patients, in newborns of mothers who are carriers of the virus, and in people who have not responded to vaccination. It is also used to prevent hepatitis B reinfection in patients who have received a liver transplant.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage human antihepatitis b immunoglobulin 200 UI/ml -
It is used to prevent reinfection by the hepatitis B virus in people who have received a liver transplant due to hepatitis B, and for the prevention of hepatitis B in cases of accidental exposure, in patients undergoing hemodialysis, in newborns of mothers who are carriers of the virus, and in people who did not respond to vaccination.
Dosage form: solution for infusion
Active substance Dosage human antihepatitis b immunoglobulin 250 UI -
It is used to treat adults, children, and adolescents who have insufficient antibody levels (such as in Primary or Secondary Immunodeficiency Syndrome) or to prevent measles in individuals who cannot be vaccinated. It is also used to treat certain autoimmune diseases such as primary immune thrombocytopenia, Guillain-Barré Syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage human polyvalent immunoglobulin 100 mg -
It is used to treat adults, children, and adolescents who do not have enough antibodies (replacement therapy) or to treat certain autoimmune conditions such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage human polyvalent immunoglobulin 50 mg -
It is used as a chronic treatment to restore balance in the lungs of patients with alpha1-antitrypsin deficiency, in order to prevent further deterioration of pulmonary emphysema.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage alpha-1 proteinase inhibitor 1000 mg -
It is used for the chronic treatment of patients with alpha1-antitrypsin deficiency. Its function is to restore balance in the lungs to prevent pulmonary emphysema from worsening.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage alpha-1 proteinase inhibitor 4.000 mg -
It is used to treat adults with low platelet counts due to chronic immune thrombocytopenia (ITP), when previous treatments have not been effective.
Dosage form: tablets, film-coated
Active substance Dosage fostamatinib disodium hexahydrate 126.2 mg -
It is used to treat adults with low platelet counts due to chronic immune thrombocytopenia (ITP), when previous treatments have not been effective.
Dosage form: tablets, film-coated
Active substance Dosage fostamatinib disodium hexahydrate 189.3 mg -
It is used to treat adults, children, and adolescents who have very low levels of antibodies (immunoglobulins) due to conditions such as primary immunodeficiency syndrome, hypogammaglobulinemia related to chronic lymphocytic leukemia or multiple myeloma, and following a stem cell transplant.
Dosage form: solution for injection
Active substance Dosage normal human immunoglobulin 18-22 PORCENTAJE